Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007629 220011690 1.66 45.2 Disease modification (D) 2017-10-01 2017-12-05 AML16 DA 3+10 N N 220032814 AML16 TRIAL
220007630 220003016 1.67 108 null 2017-01-23 2017-01-30 GEMCARBO N N 220032817 GEMCARBO
220007631 220003017 null 86 Disease modification (D) null 2013-12-06 AML16 DA 3+10 N null 220032820 AML16 TRIAL
220007632 220003017 1.82 74.1 Palliative (P) 2017-04-11 2017-04-19 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220032820 CISPLATIN + GEMCITABINE
220007633 220003018 1.61 52 Palliative (P) 2013-03-11 2013-03-11 GemCarbo Days 1+8 02 null 220032825 GEMCARBO
220007634 220003019 1.6 82.6 null 2016-03-21 2016-03-22 CISPLATIN + GEMCITABINE 02 N 220032826 CISPLATIN + GEMCITABINE
220007635 220003020 1.76 0 null 2017-07-29 2017-08-11 CISPLATIN + GEMCITABINE 2 N 220032827 CISPLATIN + GEMCITABINE
220007636 220003021 null 76.8 null null 2014-08-23 IDARUBICIN + TRETINOIN null N 220032828 IDARUBICIN + TRETINOIN
220007637 220011692 null 92.1 Disease modification (D) 2013-10-25 2013-10-28 AML 18 TRIAL 01 N 220032832 AML18 TRIAL
220007638 220011692 1.85 88.8 null 2015-01-07 2015-01-11 AML 18 TRIAL Y N 220032832 AML18 TRIAL
220007639 220003022 null 47.2 Palliative (P) 2013-10-23 2013-10-23 AML16 DA 3+10 02 N 220032836 AML16 TRIAL
220007640 220003023 1.79 73.9 Palliative (P) 2017-11-26 2017-12-19 Carboplatin + Paclitaxel (3 weekly) N N 220032838 CARBOPLATIN + PACLITAXEL
220007641 220003023 1.7 null Curative (C) 2015-07-13 2015-07-19 AML16 DA 3+10 null N 220032838 AML16 TRIAL
220007642 220003023 1.65 null Palliative (P) 2016-03-31 2016-04-04 Cisplatin + Gemcitabine (D 1 & 8) N N 220032838 CISPLATIN + GEMCITABINE
220007643 220003023 1.83 71 Curative (C) 2013-03-02 2013-03-02 AML 18 TRIAL Y null 220032838 AML18 TRIAL
220007644 220003023 1.62 81.7 null null 2015-07-13 AML16 DA 3+10 N Y 220032838 AML16 TRIAL
220007645 220003023 0 125 Palliative (P) 2015-05-31 2015-07-06 Carboplatin + Paclitaxel (3 weekly) N N 220032838 CARBOPLATIN + PACLITAXEL
220007646 220003024 1.87 88 Curative (C) 2013-02-09 2013-02-14 AML16 DA 3+10 02 N 220032846 AML16 TRIAL
220007647 220003024 1.59 47.5 Palliative (P) null 2015-05-15 Carboplatin + Paclitaxel (weekly) 02 null 220032846 CARBOPLATIN + PACLITAXEL
220007648 220003024 1.63 89 Palliative (P) 2016-03-21 2016-03-29 GEMCARBO N N 220032846 GEMCARBO
220007649 220003024 1.77 73.5 Disease modification (D) 2013-01-31 2013-01-31 AML18 PILOT TRIAL 1 N 220032846 PILOT TRIAL
220007650 220003025 null null Curative (C) 2015-05-08 2015-05-09 IDARUBICIN + TRETINOIN N N 220032856 IDARUBICIN + TRETINOIN
220007651 220003026 1.65 88.5 null 2016-09-08 2016-09-09 CISPLATIN + GEMCITABINE 02 N 220032859 CISPLATIN + GEMCITABINE
220007652 220003027 0 72.5 null null 2016-04-21 AML16 DA 3+10 N N 220032862 AML16 TRIAL
220007653 220003028 1.79 70.3 Curative (C) 2016-06-24 2016-06-24 AML 18 TRIAL N null 220032863 AML18 TRIAL
220007654 220003029 0 61 Neo-adjuvant (N) 2015-10-16 2015-10-26 Dasatinib N N 220032865 DASATINIB
220007655 220003029 null null Curative (C) null 2014-04-05 AML 18 TRIAL 1 N 220032865 AML18 TRIAL
220007656 220003030 1.83 139.7 Palliative (P) 2015-03-25 2015-03-26 Dasatinib 2 N 220032870 DASATINIB
220007657 220003031 1.71 null Curative (C) 2017-04-02 2017-04-03 AML 18 TRIAL Y N 220032871 AML18 TRIAL
220007658 220003031 null null Disease modification (D) 2017-06-27 2017-06-28 AML 18 TRIAL N null 220032871 AML18 TRIAL
220007659 220003031 1.67 96.4 Curative (C) 2014-05-20 2014-05-20 Carboplatin + Paclitaxel (3 weekly) N N 220032871 CARBOPLATIN + PACLITAXEL
220007663 220003033 1.75 86 Curative (C) null 2014-06-20 AML 18 Pilot Trial N null 220032881 PILOT TRIAL
220007664 220003034 1.61 71 Curative (C) 2017-05-01 2017-05-03 IDARUBICIN + TRETINOIN N N 220032882 IDARUBICIN + TRETINOIN
220007665 220003034 1.7 48.9 Palliative (P) 2014-12-21 2015-01-05 CARBOPLATIN + GEMCITABINE 02 N 220032882 GEMCARBO
220007666 220003034 1.72 80 Curative (C) 2017-04-04 2017-04-04 AML 18 TRIAL N N 220032882 AML18 TRIAL
220007667 220003035 1.8 76.9 Curative (C) null 2013-02-02 AML16 Low Dose Cytarabine 02 N 220032887 AML16 TRIAL
220007670 220003037 1.49 86.3 null 2015-07-03 2015-07-03 IDARUBICIN + TRETINOIN N N 220032893 IDARUBICIN + TRETINOIN
220007671 220003038 1.85 87.5 Curative (C) 2016-11-21 2016-11-21 AML 18 TRIAL Y N 220032898 AML18 TRIAL
220007672 220003038 1.6 85.7 null 2017-02-23 2017-02-23 AML16 DA 3+10 02 N 220032898 AML16 TRIAL
220007673 220003038 1.84 84.6 Curative (C) 2016-10-04 2016-10-04 AML 18 TRIAL 1 N 220032898 AML18 TRIAL
220007674 220003038 1.75 null Palliative (P) 2014-11-19 2014-11-19 GemCarbo Days 1+8 N N 220032898 GEMCARBO
220007675 220020435 1.8 null Curative (C) 2017-09-20 2017-09-21 AML 18 TRIAL Y N 220032905 AML18 TRIAL
220007676 220003039 1.61 null Curative (C) 2017-11-07 2017-11-08 Dasatinib 02 N 220032908 DASATINIB
220007677 220003040 1.6 87.6 Palliative (P) 2014-04-06 2014-04-15 GEMCARBO N null 220032909 GEMCARBO
220007678 220003041 1.61 0 Not known (9) 2015-06-15 2015-06-15 IDARUBICIN + TRETINOIN N null 220032911 IDARUBICIN + TRETINOIN
220007679 220003042 1.6 null Palliative (P) 2013-07-02 2013-07-17 GemCarbo Days 1+8 N null 220032915 GEMCARBO
220007682 220003043 1.61 45.2 Palliative (P) 2014-06-23 2014-08-03 Cisplatin+Gemcitabine (gallbladder) 02 N 220032918 CISPLATIN + GEMCITABINE
220007683 220003043 1.76 0 Curative (C) 2014-09-13 2014-09-13 AML18 PILOT TRIAL null Y 220032918 PILOT TRIAL
220007684 220003044 1.82 73 Curative (C) 2015-01-06 2015-01-06 CARBOPLATIN + PACLITAXEL 02 null 220032920 CARBOPLATIN + PACLITAXEL
220007685 220003044 1.57 67.3 Curative (C) 2014-11-10 2014-11-18 CARBOPLATIN + PACLITAXEL 02 N 220032920 CARBOPLATIN + PACLITAXEL